1580
LIU AnHua, et al. Sci China Chem July (2010) Vol.53 No.7
128.9, 138.9, 158.0; ESI-MS calcd for C12H15NO2 205.11,
found m/z 206.30 (M+H)+, 228.30 (M +Na)+, 433.04 (2M+
Na)+.
2.31 (s, 3H), 2.36–2.48 (m, 2H), 7.09–7.15 (m, 4H); 13C
NMR (100 MHz, CDCl3) ppm 12.6, 21.2, 38.9, 51.6, 74.3,
125.6, 129.5, 135.8, 138.7, 157.7; ESI-MS calcd for
C12H15NO2 205.25, found m/z 206.45 (M + H)+, 411.15 (2M
+ H)+.
3-butyl-5-phenyloxazolidin-2-one (2e)
Colorless liquid. 1H NMR (300 MHz, CDCl3) ppm 0.93 (t,
3J = 7.4 Hz, 3H), 1.31–1.64 (m, 4H), 3.23–3.35 (m, 2H),
5-(4-Chlorophenyl)-3-ethyloxazolidin-2-one (2k)
3
3
White solid, mp: 70–74 °C. 1H NMR (400 MHz, CDCl3)
3.43 (t, J = 8.1 Hz, 1H), 3.91 (t, J = 8.9 Hz, 1H), 5.49 (t,
3J = 8.1 Hz, 1H), 7.34–7.44 (m, 5H); 13C NMR (75 MHz,
CDCl3) ppm 13.4, 19.5, 29.1, 43.6, 51.8, 74.1, 125.2,
128.4, 128.5, 138.7, 157.7; ESI-MS calcd for C13H17NO2
219.13, found m/z 220.34 (M + H)+, 259.48 (M + K)+,
461.05 (2M + Na)+.
ppm 1.17 (t, 3J = 7.3 Hz, 3H), 3.30–3.43 (m, 2H), 3.69–3.76
3
3
(m, 1H), 3.92 (t, J = 8.7 Hz, 1H), 5.44 (t, J = 8.0 Hz, 1H),
7.27–7.38 (m, 4H); 13C NMR (100 MHz, CDCl3) ppm
12.6, 38.9, 51.5, 73.6, 126.9, 129.1, 134.7, 137.4, 157.4;
ESI-MS calcd for C11H12ClNO2 225.67, found m/z 451.64
(2M + H)+.
3-Isobutyl-5-phenyloxazolidin-2-one (2f)
1
1,4-Diethyl-2,5-diphenylpiperazine (4a)
White solid, mp: 38–42 °C. H NMR (400 MHz, CDCl3)
ppm 0.93 (d, 3J = 6.8 Hz, 6H), 1.85–1.92 (m, 1H), 3.04–3.17
White solid, mp: 116–119 °C. H NMR (300 MHz, CDCl3)
1
3
3
3
(m, 2H), 3.43 (t, J = 8.0 Hz, 1H), 3.92 (t, J = 8.8 Hz, 1H),
ppm 0.91 (t, J = 7.2 Hz, 6H), 1.99–2.05 (m, 2H), 2.30 (t,
5.50 (t, J = 8.2 Hz, 1H), 7.35–7.41 (m, 5H); 13C NMR (100
3
3J = 10.8 Hz, 2H), 2.54–2.62 (m, 2H), 3.08 (dd, 3J=11.6 Hz,
2
3
MHz, CDCl3) ppm 18.8, 18.9, 25.8, 50.8, 51.8, 73.3,
124.4, 127.7, 127.9, 137.9, 158.0; ESI-MS calcd for
C13H17NO2 219.13, found m/z 461.22 (2M + Na)+, 679.70
(3M + Na)+.
2J = 2.4 Hz, 2H), 3.45 (dd, J = 2.0 Hz, J = 12.0 Hz, 2H),
7.29–7.43 (m, 10H); HRMS calcd for C20H26N2 (M + H)+
295.2169, found m/z 295.2164.
1,4-Diethyl-2,3-diphenyl-piperazine (5a)
Colorless liquid. 1H NMR (300 MHz, CDCl3) ppm 1.01 (t,
3-Tert-butyl-5-phenyloxazolidin-2-one (2g)
Colorless liquid. 1H NMR (300 MHz, CDCl3) ppm 1.41 (s,
9H), 3.45 (t, 3J = 8.4 Hz , 1H), 3.95 (t, 3J=8.7 Hz, 1H), 5.36
(t, 3J = 8.1 Hz, 1H), 7.32–7.41 (m, 5H); 13C NMR (75 MHz,
CDCl3) ppm 27.3, 50.9, 53.5, 73.4, 125.4, 128.5, 128.7,
138.9, 156.6; ESI-MS calcd for C13H17NO2 219.13, found
m/z 242.46 (M + Na)+, 259.30 (M + K)+.
3J = 7.2 Hz, 6H), 2.17–2.26 (m, 2H), 2.33–2.26 (m, 2H),
3
2.65–2.69 (m, 2H), 2.95–2.99 (q, J = 6.0 Hz, 2H), 3.73 (s,
3
2H), 7.27–7.38 (m, 6H), 7.69–7.71 (d, J = 7.2 Hz, 4H);
HRMS: calcd for C20H26N2 (M + H)+ 295.2169, found
295.2167.
4-phenyldioxolan-2-one (7a)
1
3-Cyclohexyl-5-phenyloxazolidin-2-one (2h)
White solid, mp: 55–56 °C. H NMR (400 MHz, CDCl3)
3
3
1
ppm 4.35 (t, J = 8.4 Hz, 1H), 4.80 (t, J=8.4 Hz, 1H), 5.68
White solid, mp: 92–93 °C. H NMR (400 MHz, CDCl3)
3
ppm 1.13–1.9 (m, 10H), 3.40 (t, 3J = 8.0 Hz, 1H), 3.72–3.78
(t, J = 8.0 Hz, 1H), 7.36–7.38 (m, 2H), 7.43–7.47 (m, 3H);
3
3
13C NMR (100 MHz, CDCl3) ppm 71.1, 78.0, 125.9,
129.3, 129.8, 135.8, 154.8; ESI-MS calcd for C9H8O3
164.16, found m/z 351.26 (2M + Na)+, 367.68 (2M + K)+.
(m, 1H), 3.88 (t, J = 8.8 Hz, 1H), 5.47 (t, J = 8.2 Hz, 1H),
7.34–7.42 (m, 5H); 13C NMR (100 MHz, CDCl3) ppm
25.1, 25.2, 29.9, 30.3, 48.1, 52.4, 74.4, 125.3, 128.5, 128.7,
138.9, 157.0; ESI-MS calcd for C15H19NO2 245.14, found
m/z 246.27 (M + H)+, 757.70 (3M + Na)+.
3-Benzyl-5-methyleneoxazolidin-2-one (9a)
1
Light yellow solid, mp: 51–52 °C. H NMR (400 MHz,
CDCl3) ppm 4.02 (t, 3J=2.4 Hz, 2H), 4.24 (dd, 3J=5.2 Hz,
3-Benzyl-5-phenyloxazolidin-2-one (2i)
1
3
2J = 2.4 Hz, 1H), 4.47 (s, 2H), 4.74 (dd, J = 5.6 Hz, 3J=2.8
White solid, mp: 60–64 °C. H NMR (400 MHz, CDCl3)
3
3
Hz, 1H), 7.29–7.39 (m, 5H); 13C NMR (100 MHz, CDCl3)
ppm 47.2, 47.8, 86.8, 128.2, 129.0, 134.9, 148.9, 155.6;
ESI-MS calcd for C11H11NO2 189.21, found m/z 410.29 (2M
+ Na)+.
ppm 3.31 (t, J = 8.0 Hz, 1H), 3.77 (t, J=8.8 Hz, 1H), 4.48
3
(ABq, JAB = 15.2 Hz, vAB = 37.8 Hz, 2H), 5.47 (t, J = 8.2
Hz, 1H), 7.28–7.38 (m, 10H); 13C NMR (100 MHz, CDCl3)
ppm 48.4, 51.6, 74.5, 125.5, 128.0, 128.2, 128.8, 128.9,
135.6, 138.6, 158.0; ESI-MS calcd for C16H15NO2 253.11,
found m/z 276.44 (M + Na)+, 781.66 (3M + Na)+.
2.3 General procedure for the coupling reaction with CS2
3-Ethyl-5-p-tolyloxazolidin-2-one (2j)
In a 25 mL autoclave reactor with a quartzose tube and a
magnetic stirrer, the substrate (1 mmol), catalyst (ion-ex-
change resin, 0.05 mmol), and biphenyl (50 mg) were
charged. Then CS2 (1 mL) was added into the autoclave.
White solid, mp: 48–50 °C. 1H NMR (400 MHz, CDCl3)
ppm 1.18 (t, 3J = 7.3 Hz, 3H), 1.62 (d, 3J=6.4 Hz, 1H), 1.87
3
3
2
(d, J = 3.2 Hz, 1H), 2.27 (dd, J = 6.6 Hz, J = 3.2 Hz, 1H),